Novartis is satisfied with LCZ696 heart disease drug
Novartis, a Swiss drug manufacturing company, has expressed satisfaction with its LCZ696 chronic heart disease treatment drug. This drug has shown dramatic effectiveness in treating heart disease patients that ...